Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Experimental Medicine|July 11, 2025
Bone marrow neutrophil density regulates myelopoiesis during obesity and weight lossQuin T Waterbury, Jin Qian, Hualong Zheng, et al.Cancer Cell|June 27, 2025
A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesisJin Qian, Chenkai Ma, Quin T Waterbury, et al.Biorxiv : the Preprint Server for Biology|October 17, 2024
A CXCR4 partial agonist improves immunotherapy by targeting polymorphonuclear myeloid-derived suppressor cells and cancer-driven granulopoiesisJin Qian, Chenkai Ma, Quin T Waterbury, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 11, 2020
Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinomaHualong Zheng, YaJun Zhao, Qingliang He, et al.Cancer|December 9, 2025
Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trialJun Zhang, Yanqiao Zhang, Haibo Qiu, et al.Cancer Research|December 31, 2025
Netrin-1 Promotes Pancreatic Tumorigenesis and Innervation through NEO1Hiroki Kobayashi, Yosuke Ochiai, Junya Arai, et al.Biorxiv : the Preprint Server for Biology|August 8, 2025
Netrin-1 promotes pancreatic tumorigenesis and innervation through NEO1Yosuke Ochiai, Hiroki Kobayashi, Masaki Sunagawa, et al.European Journal of Cancer (Oxford, England : 1990)|November 19, 2023
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in ChinaJian Li, Jun Zhang, Yanqiao Zhang, et al.Pageof 2